These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 14071494)

  • 21. [Study of the catalase and peroxidase activities of avian mycobacteria, as a function of their resistance to I.N.H].
    ANDREJEW A
    Ann Inst Pasteur Lille; 1958-1959; 10():37-41. PubMed ID: 14013026
    [No Abstract]   [Full Text] [Related]  

  • 22. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis.
    Zhao JR; Bai YJ; Wang Y; Zhang QH; Luo M; Yan XJ
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):328-32. PubMed ID: 15786899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil.
    Höfling CC; Pavan EM; Giampaglia CM; Ferrazoli L; Aily DC; de Albuquerque DM; Ramos MC
    Int J Tuberc Lung Dis; 2005 Jan; 9(1):87-93. PubMed ID: 15675556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial susceptibility testing of Mycobacterium tuberculosis (EUCAST document E.DEF 8.1)--report of the Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
    Drobniewski F; Rüsch-Gerdes S; Hoffner S;
    Clin Microbiol Infect; 2007 Dec; 13(12):1144-56. PubMed ID: 17727670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High rates of multidrug-resistant Mycobacterium tuberculosis in Sinaloa State, Mexico.
    Zazueta-Beltran J; Muro-Amador S; Flores-Gaxiola A; Llausas-Magaña E; León-Sicairos N; Canizalez-Roman A
    J Infect; 2007 Apr; 54(4):411-2. PubMed ID: 16730800
    [No Abstract]   [Full Text] [Related]  

  • 28. [Catalase activity and virulence of Mycobacterium tuberculosis resistant to isonicotinic acid hydrazide].
    STRUPCZEWSKA-JANUSZOWA H
    Gruzlica (1926); 1959 Feb; 27(2):117-24. PubMed ID: 13664103
    [No Abstract]   [Full Text] [Related]  

  • 29. [Simplified process for identification of catalase and dehydrogenase in Mycobacteria].
    ALMEDIA RC; BARRETO HS
    Rev Bras Tuberc Doencas Torac; 1958 Mar; 26(191):393-400. PubMed ID: 13542889
    [No Abstract]   [Full Text] [Related]  

  • 30. [Catalase activity of Mycobacterium tuberculosis].
    SCHWEIGER O
    Probl Tuberk; 1962; 40(6)():88-91. PubMed ID: 13987456
    [No Abstract]   [Full Text] [Related]  

  • 31. [Primary resistance in tuberculosis].
    KREIS B
    Torax; 1962 Mar; 11():1-9. PubMed ID: 14035682
    [No Abstract]   [Full Text] [Related]  

  • 32. [The acid-fast rod].
    Bassermann FJ
    Prax Pneumol; 1971 Jan; 25(1):1-9. PubMed ID: 4994259
    [No Abstract]   [Full Text] [Related]  

  • 33. [Qualitative studies on catalases of Mycobacterium tuberculosis].
    POLSTER M
    Lek List; 1953 Dec; 8(23):556-7. PubMed ID: 13131914
    [No Abstract]   [Full Text] [Related]  

  • 34. Experimental studies on the mechanism of bacteriostatic action of isonicotinic acid hydrazid (INAH). III. On the influences of INAH on catalase of BCG.
    SAKAI J; ITO F
    Kekkaku; 1954 Jul; 29(7):237-8; English abstract, 272. PubMed ID: 13184591
    [No Abstract]   [Full Text] [Related]  

  • 35. [Extraction of catalase from the B-5 acid-fast saprophyte].
    Pershin GN; Fadeeva NI
    Probl Tuberk; 1965; 43(4):74-7. PubMed ID: 5853729
    [No Abstract]   [Full Text] [Related]  

  • 36. [Behavior and significance of cytochemical reactions and catalase activity in tubercular mycobacteria; experimental study].
    RESCIGNO B; ALIPERTA A
    Arch Tisiol Mal Appar Respir; 1958 Dec; 13(12):1065-80. PubMed ID: 13650958
    [No Abstract]   [Full Text] [Related]  

  • 37. [Some properties of purified catalase of the B5 acid-fast saprophyte].
    Pershin GN; Fadeeva NI
    Probl Tuberk; 1969; 47(4):76-9. PubMed ID: 5368448
    [No Abstract]   [Full Text] [Related]  

  • 38. On the importance of atypical acid-fast organisms as pathogenic agents.
    VIRTANEN S
    Acta Tuberc Scand; 1961; 40():190-4. PubMed ID: 13781564
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experimental production of grains surrounded by clubs around aggregates of acid-fast Mycobacterium tuberculosis].
    BRETEY J; LEVADITI JC; PICK F
    Ann Inst Pasteur (Paris); 1957 Jul; 93(1):123-7. PubMed ID: 13470424
    [No Abstract]   [Full Text] [Related]  

  • 40. RECENT TRENDS IN IDENTIFICATION AND SENSITIVITY TESTING OF ACID FAST ORGANISMS.
    CRECELIUS HG; DEAN WW
    Ariz Med; 1963 Oct; 20():219-20. PubMed ID: 14071494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.